A prospective study of alcoholism and the risk of Parkinson’s disease

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Neurology

• Publication date

  2004-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00415-004-1705-4PMID 15505749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validity of the General Practice Research Database

  2003cited by this paper
• Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease

  2003cited by this paper
• Alcohol consumption and the incidence of Parkinson's disease

  2003cited by this paper
• Footprints of coagulopathy

  2002cited by this paper
• A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

  2002cited by this paper
• Cigarette smoking and the incidence of Parkinson's disease in two prospective studies

  2001cited by this paper
• Neuroprotection by Caffeine and A2A Adenosine Receptor Inactivation in a Model of Parkinson's Disease

  2001cited by this paper
• Sleep disordered breathing in patients with cluster headache

  2001cited by this paper
• Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco.

  2001cited by this paper
• Dose‐related neuroprotective effects of chronic nicotine in 6‐hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice

  2001cited by this paper
• Prospective study of caffeine consumption and risk of Parkinson's disease in men and women

  2001cited by this paper
• The personality associated with Parkinson’s disease

  2000cited by this paper
• Influence of strict, intermediate, and broad diagnostic criteria on the age‐ and sex‐specific incidence of Parkinson's disease

  2000cited by this paper
• Smoking, alcohol, and coffee consumption preceding Parkinson’s disease

  2000cited by this paper
• Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990

  1999cited by this paper
• Parkinsonian features: when are they Parkinson disease?

  1998cited by this paper
• Use of the UK General Practice Research Database for pharmacoepidemiology.

  1998cited by this paper
• Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease.

  1994cited by this paper
• Further validation of information recorded on a general practitioner based computerized data resource in the united kingdom

  1992cited by this paper
• Is there a premorbid personality typical for Parkinson's disease?

  1991cited by this paper
• Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.

  1991cited by this paper
• Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke.

  1990cited by this paper
• MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra.

  1989cited by this paper
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde.

  1987cited by this paper
• How valid is the clinical diagnosis of Parkinson ’ s disease in the community ?

  year unknowncited by this paper

• Exposure to disulfiram and incidence of parkinsonism

  2025cites this paper
• The epidemiological risk and prevention and interventions in Parkinson's disease: from a nutrition-based perspective.

  2025cites this paper
• Influenza Immunization at Midlife and the Risk of Parkinson Disease

  2025cites this paper
• Identifying and Predicting Risk for Hospital Admission among Patients with Parkinsonism

  2024cites this paper
• Upper Gastrointestinal Mucosal Damage and Subsequent Risk of Parkinson Disease

  2024cites this paper
• Alcohol and Parkinson’s Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• Life style and Parkinson’s disease

  2022cites this paper
• Aromatase inhibitors and the incidence of Parkinson disease: A population‐based cohort study

  2022cites this paper
• NSAID use is not associated with Parkinson’s disease incidence: A Norwegian Prescription Database study

  2021cites this paper
• Parkinson's Disease Risk and Alcohol Intake: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies

  2021influential citation
• Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes

  2020cites this paper
• Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis

  2020cites this paper
• Monomicrobial gram-negative necrotizing fasciitis: An uncommon but fatal syndrome.

  2019cites this paper
• Nutritional Risk Factors, Microbiota and Parkinson’s Disease: What Is the Current Evidence?

  2019cites this paper
• Identifying Parkinson's disease and parkinsonism cases using routinely collected healthcare data: A systematic review

  2019cites this paper
• Increased risk of all‐cause mortality associated with domperidone use in Parkinson's patients: a population‐based cohort study in the UK

  2018cites this paper
• Identifying Parkinson’s disease and parkinsonism cases using routinely-collected healthcare data: a systematic review

  2018cites this paper
• Short‐ and long‐term cost and utilization of health care resources in Parkinson's disease in the UK

  2018cites this paper
• Parkinson disease and the risk of epileptic seizures

  2018cites this paper
• Parkinson disease and musculoskeletal pain: an 8-year population-based cohort study

  2017cites this paper
• Increased Prevalence of Polyneuropathy in Parkinson’s Disease Patients: An Observational Study

  2017cites this paper
• Simvastatin is associated with decreased risk of Parkinson disease

  2017influential citation
• Glitazone use associated with reduced risk of Parkinson's disease

  2017cites this paper
• Parkinsonism and Related Disorders

  2016cites this paper
• Diet, lifestyle factors, metabolic health and risk of Parkinson s disease : A prospective cohort study

  2016cites this paper
• Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study

  2015cites this paper
• Alcohol Consumption and Parkinson’s Disease Risk: A Review of Recent Findings

  2015influential citation
• Population-based studies on risk of fracture in patients with neurological disorders

  2014influential citation
• Role of PPARγ in the Differentiation and Function of Neurons

  2014influential citation
• Alcohol intake and risk of Parkinson's disease: A meta‐analysis of observational studies

  2014cites this paper
• Acetaldehyde and parkinsonism: role of CYP450 2E1

  2013cites this paper
• Five-year fracture risk estimation in patients with Parkinson's disease.

  2013cites this paper
• Discontinuation of statin therapy associates with Parkinson disease

  2013cites this paper
• Alcohol use disorders and risk of Parkinson’s disease: findings from a Swedish national cohort study 1972–2008

  2013cites this paper
• Risk of fracture in patients with Parkinson’s disease

  2013cites this paper
• Neuropsychological alterations of a patient with Parkinson's disease and background psychoactive substance use

  2012cites this paper
• Cigarette smoking, coffee intake and alcohol consumption preceding Parkinson's disease: a case–control study

  2012cites this paper
• Alteraciones neuropsicológicas de un paciente con enfermedad de Parkinson y antecedentes de consumo de sustancias psicoactivas

  2012cites this paper
• Risk of incident depression in patients with Parkinson disease in the UK

  2011cites this paper
• Parkinson’s disease or Parkinson symptoms following seasonal influenza

  2011cites this paper
• NSAID use and risk of Parkinson disease: a population‐based case‐control study

  2011cites this paper
• Estrogen-related and other disease diagnoses preceding Parkinson’s disease

  2010cites this paper
• Risk of stroke in patients with idiopathic Parkinson disease.

  2010cites this paper
• Cancer risk in association with Parkinson disease: a population-based study.

  2010cites this paper
• Multifocal acquired demyelinating sensory and motor neuropathy presenting as idiopathic hypertrophic brachial neuropathy

  2009cites this paper
• Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study.

  2009cites this paper
• Use of antidepressants and the risk of Parkinson’s disease: a prospective study

  2009cites this paper
• Diabetes in Patients With Idiopathic Parkinson's Disease

  2008cites this paper
• Use of antihypertensives and the risk of Parkinson disease

  2008cites this paper
• Gout and the risk of Parkinson's disease: a cohort study.

  2008cites this paper
• Use of Statins and the Risk of Parkinson’s Disease

  2008cites this paper
• Epidemiology of Parkinson's disease

  2007cites this paper
• Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle

  2007cites this paper
• Gout and risk of Parkinson disease

  2007cites this paper
• Non-steroidal anti-inflammatory drugs in Parkinson's disease.

  2007cites this paper
• Population-based studies on the epidemiology of migraine and Parkinson's disease

  2007cites this paper
• Adiponectin protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity.

  2006cites this paper
• Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease

  2006cites this paper
• Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity.

  2006cites this paper
• Theoretical Biology and Medical Modelling Activation Instead of Blocking Mesolimbic Dopaminergic Reward Circuitry Is a Preferred Modality in the Long Term Treatment of Reward Deficiency Syndrome (rds): a Commentary

  year unknowncites this paper